CULLINAN THERAPEUTICS, INC. — Net Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/e5d0f2e1-93d1-4f39-8145-44f7e9a92571/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-219.9M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-099362 |
| FY 2024 | $-167.6M | 2024-01-01 – 2024-12-31 | evidence 0001193125-26-183465 |
| FY 2023 | $-155.1M | 2023-01-01 – 2023-12-31 | evidence 0001193125-26-183465 |
| FY 2022 | $111.2M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-006839 |
| FY 2021 | $-65.6M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-004002 |
| FY 2020 | $-51.8M | 2020-01-01 – 2020-12-31 | evidence 0000950170-22-004002 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CULLINAN THERAPEUTICS, INC. — all facts · Revenue · Operating Income